SNX2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.281900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.075600E-02
Normal-vs-Stage2
1.422140E-02
Normal-vs-Stage3
1.020250E-01
Normal-vs-Stage4
3.724000E-01
Stage1-vs-Stage2
7.382200E-01
Stage1-vs-Stage3
3.769000E-01
Stage1-vs-Stage4
3.758600E-01
Stage2-vs-Stage3
6.283400E-01
Stage2-vs-Stage4
2.626200E-01
Stage3-vs-Stage4
2.281400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.229940E-02
Normal-vs-AfricanAmerican
1.911990E-01
Normal-vs-Asian
2.192400E-02
Caucasian-vs-AfricanAmerican
7.417600E-01
Caucasian-vs-Asian
1.145230E-01
AfricanAmerican-vs-Asian
2.816600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.675790E-02
Normal-vs-Female
1.423590E-02
Male-vs-Female
5.397800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.059580E-01
Normal-vs-Age(41-60Yrs)
3.017800E-02
Normal-vs-Age(61-80Yrs)
1.342090E-02
Normal-vs-Age(81-100Yrs)
1.739600E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.461400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.049400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.754800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.250300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.328150E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.695400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.281200E-03
Normal-vs-Daily Drinker
7.338600E-03
Normal-vs-Weekly Drinker
4.581600E-02
Normal-vs-Occasional Drinker
5.440200E-02
Normal-vs-Social Drinker
8.296400E-02
Non Drinker-vs-Daily Drinker
6.010400E-01
Non Drinker-vs-Weekly Drinker
4.126600E-01
Non Drinker-vs-Occasional Drinker
1.307950E-01
Non Drinker-vs-Social Drinker
1.586410E-01
Daily Drinker-vs-Weekly Drinker
6.949600E-01
Daily Drinker-vs-Occasional Drinker
3.034400E-01
Daily Drinker-vs-Social Drinker
3.331800E-01
Weekly Drinker-vs-Occasional Drinker
6.248200E-01
Weekly Drinker-vs-Social Drinker
6.395400E-01
Occasional Drinker-vs-Social Drinker
9.801400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.017400E-01
Normal-vs-Grade 2
7.896000E-01
Normal-vs-Grade 3
7.888200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.168400E-01
Grade 1-vs-Grade 3
2.241400E-01
Grade 1-vs-Grade 4
7.017400E-01
Grade 2-vs-Grade 3
9.821200E-01
Grade 2-vs-Grade 4
7.896000E-01
Grade 3-vs-Grade 4
7.888200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.151600E-02
Normal-vs-NonDiabetic
4.160900E-03
Diabetic-vs-NonDiabetic
1.892820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.481520E-02
Normal-vs-NoPancreatitis
1.076280E-02
Pancreatitis-vs-NoPancreatitis
5.562600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.113500E-02
Normal-vs-N1
1.177570E-02
N0-vs-N1
8.096600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.419600E-03
Normal-vs-TP53-NonMutant
2.330200E-02
TP53-Mutant-vs-TP53-NonMutant
6.107600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
